Markets

  • Silver47 Exploration: OTC Markets Inquiry

    Silver47 Exploration (AAGAF) addressed promotional activities following an inquiry from OTC Markets Group. The company engaged Sideways Frequency LLC for investor relations and Market One Media Group for $75,000 in investor lead generation and media services. Silver47 asserts editorial control over marketing materials, ensuring factual accuracy. A director purchased 100,000 units, signaling confidence, but the promotional impact on trading volume is noted. Silver47 clarifies relationships with investor relations firms, confirming no discounted securities were issued.

    2025年9月18日
  • Mounjaro (Tirzepatide) Significantly Improves A1C in Pediatric Type 2 Diabetes: Phase 3 Trial Results.

    The SURPASS-PEDS Phase 3 trial evaluated Mounjaro (tirzepatide) in pediatric patients (10-17) with type 2 diabetes. Mounjaro significantly reduced A1C and BMI compared to placebo after 30 weeks, improvements sustained through 52 weeks. 86.1% of subjects on 10mg Mounjaro achieved an A1C target ≤6.5%. The safety profile was consistent with adult studies. Lilly seeks regulatory approval to expand Mounjaro’s label for this younger population, addressing a critical unmet need given the rise of type 2 diabetes in children.

    2025年9月18日
  • Greenidge Generation Sells Mississippi Bitcoin Mining Operation

    Greenidge Generation Holdings Inc. (Nasdaq: GREE) sold its Columbus, Mississippi bitcoin mining facility to US Digital Mining Mississippi LLC on September 16, 2025, for $3.9 million. The sale reflects Greenidge’s strategic shift amid volatile cryptocurrency market conditions and declining bitcoin mining profitability. Analysts suggest it may signal industry consolidation. The facility’s infrastructure and power capacity are important factors for the new owner. Greenidge aims to streamline operations, potentially focusing on power generation and other datacenter applications.

    2025年9月18日
  • The TJX Companies Announces Quarterly Dividend

    On September 17, 2025, The TJX Companies, Inc. (TJX) announced a quarterly dividend of $0.425 per share, payable on December 4, 2025, to shareholders of record on November 13, 2025. TJX, a leading off-price retailer operating over 5,100 stores worldwide, emphasizes value to shareholders through consistent dividend payouts. The company’s success is attributed to its strong buying power, efficient supply chain, and omnichannel approach blending physical and digital retail. TJX also focuses on corporate responsibility.

    2025年9月18日
  • Retrieve Medical, Partnering with ID.me, Enhances Security and Simplifies Access to Patient Health Records via Health Information Exchanges

    Retrieve Medical Holdings, Inc. is launching Retrieve Personal, a platform providing secure, immediate access to comprehensive medical records for patients and providers. Integrating with Health Information Exchanges (HIEs) and leveraging AI, Retrieve Personal compiles complete patient histories into actionable summaries. ID.me provides secure identity verification. This initiative addresses fragmented patient information but faces challenges like HIE interoperability and data standardization. The aim is portable health summaries, enhancing personalized healthcare and improving efficiency.

    2025年9月18日
  • Mercury Insurance Adopts XyloPlan and Milliman Wildfire Risk Solution

    Mercury Insurance is integrating XyloPlan’s building-level Wildfire Risk Scores, powered by Milliman’s PinPoint API, into its underwriting process. This data-driven approach moves beyond traditional hazard maps by simulating fire spread based on vegetation, terrain, and weather. The integration provides property-specific risk assessments, enabling more accurate pricing, tailored customer guidance, and proactive mitigation strategies. This partnership highlights the insurance industry’s growing trend towards utilizing advanced technologies for wildfire risk management in response to increasing frequency and intensity.

    2025年9月18日
  • Bank of America Boosts Minimum Wage to $25/Hour, Salaries Exceed $50K

    Bank of America announced a U.S. minimum hourly wage increase to $25, effective early October 2025, impacting thousands of employees and fulfilling its $25 by 2025 pledge. This translates to over $50,000 annually for full-time employees. The company emphasizes career advancement opportunities, comprehensive benefits, and significant investment in employee development, contributing to economic growth. The move may pressure other financial institutions to raise wages and could impact Bank of America’s future performance.

    2025年9月17日
  • Empire Metals Limited: Director/PDMR Shareholding Announcement

    On September 17, 2025, Empire Metals Limited (EPMLF) announced that Managing Director Shaun Bunn purchased 40,000 ordinary shares at 36.25 pence each. This transaction increased Bunn’s total ownership to 2,251,111 shares, representing 0.32% of the company’s issued share capital. The purchase signals Bunn’s confidence in Empire Metals, a resource exploration and development company focused on the Pitfield titanium project in Western Australia and other projects in Australia and Austria.

    2025年9月17日
  • Elbit Systems Extends Shelf Prospectus in Israel

    Elbit Systems Ltd. announced that the Israel Securities Authority has extended the validity of its shelf prospectus until September 27, 2026. This extension provides Elbit Systems with continued flexibility in accessing capital markets. The company emphasized that no decision has been made regarding a specific offering, and any potential offering’s scope, terms, and timing remain undetermined. Elbit Systems reported revenues of $2.0 billion for the quarter ending June 30, 2025, and boasts a $23.8 billion order backlog.

    2025年9月17日
  • Sensorion Announces 2025 Half-Year Results, Corporate Update, and Availability of Report

    Sensorion reported positive H1 2025 results, highlighting progress in gene therapies. The Audiogene Phase 1/2 trial for SENS-501 (OTOF-GT) showed a positive safety profile and early hearing improvement signs. Enrollment in SENS-401’s Phase 2a Cisplatin-Induced Ototoxicity study is complete, with topline data expected in H2 2025. GJB2-GT is on track for a Q1 2026 CTA filing. The company’s cash position of €57.1m funds operations into Q3 2026. R&D expenses increased slightly, reflecting intensified clinical trial activities. Net loss was -€16.0 million.

    2025年9月17日